Description

Letromara Coated Tablets 2.5 mg. №30

Ingredients:

Each coated tablet contains 2.5 mg of Letrozole.

Dosage:

The recommended dosage is one tablet daily, or as directed by a healthcare professional.

Indications:

Letromara is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Contraindications:

Do not use Letromara if you are pregnant, breastfeeding, or allergic to Letrozole.

Directions:

Swallow the tablet whole with a glass of water, with or without food.

Scientific Evidence:

Studies have shown that Letrozole, the active ingredient in Letromara, is effective in reducing the risk of cancer recurrence in postmenopausal women with hormone receptor-positive breast cancer. Research published in the New England Journal of Medicine demonstrated the superior efficacy of Letrozole compared to tamoxifen in this patient population.

Additional Information:

Letromara works by inhibiting aromatase, an enzyme involved in estrogen production. By reducing estrogen levels, Letrozole helps slow or stop the growth of hormone-sensitive tumors. Clinical trials have also indicated that Letrozole may be more effective and have fewer side effects than other hormonal therapies.

It is important to follow your healthcare provider’s instructions when taking Letromara and to report any side effects promptly. Consult your doctor before starting or stopping any medication regimen.